Catalysts combination opens doors to making useful compounds

17-Aug-2018 - Researchers have developed a new method that aids in the process of making valuable compounds by using a unique combination of catalysts. Huimin Zhao, Professor of Chemical and Biomolecular Engineering and leader of the Biosystems Design research theme at the Carl R. Woese Institute for Genomic ...

AMPAC Fine Chemicals and Codexis Enter Into a Manufacturing Partnership

01-Apr-2010 - AMPAC Fine Chemicals LLC (AFC), a subsidiary of American Pacific Corporation announced that it has entered into a manufacturing partnership with Codexis, Inc. Under a new agreement, AFC will partner with Codexis to use Codexis' proprietary biocatalysis technology in combination with AFC's ...

AllessaSyntec tells Success Story after First Major Project in its New Low-Temperature Reactor

Managing Director Dr. Wisser: „With cutting edge technology we are successful in difficult times!“

22-Sep-2009 - The first major large-scale project of a multi-step synthesis of a pharmaceutical intermediate in the new 1000-liter-low-temperature reactor has recently been finished at the AllessaSyntec GmbH & Co. KG in Frankfurt-Höchst. “We have proven that the exclusive synthesis of high-value products at a ...

Special Materials Company starts new Phosphines Unit

19-Mar-2008 - Special Materials Company (SMC) reports the successful startup of its new commercial scale alkyl phosphines unit at its Changshu New Tech JV factory in Changshu, Jiangsu Province China. SMC's investment in the specialized APT (Advanced Phosphine Technology) shall bring a new reliable supply of ...

AMRI Acquires Manufacturing Facilities in India

23-May-2007 - Albany Molecular Research, Inc. has signed a definitive agreement to acquire two pharmaceutical manufacturing sites, along with additional land for future expansion, in Aurangabad and Navi Mumbai, India. Under the terms of the agreement, AMRI will acquire the assets - including facilities, ...

Rhodia plans closure of its Mulhouse Dornach site in France

27-Mar-2007 - Rhodia presented a plan to close the Mulhouse Dornach site in France to its Works Council. The closure would be effective as of December 31, 2007 . According to the company, an economic analysis of the site's business activities has clearly illustrated a difficult competitive situation being ...

Sigma-Aldrich Acquires Iropharm to Expand cGMP Capacity

05-May-2006 - Sigma-Aldrich Corporation announced that it has acquired Honeywell International's Iropharm unit, a custom chemical synthesis business located in Arklow, Ireland. The addition of Iropharm will substantially increase SAFC's active pharmaceutical ingredient (API) and pharmaceutical intermediates ...

Degussa and Hikal sign manufacturing agreement

16-Mar-2006 - The Exclusive Synthesis & Catalysts business unit of Degussa AG, Dusseldorf, Germany, has announced that it has signed a long-term, non-exclusive agreement with Hikal Ltd., India, for a cooperation on the manufacture of pharmaceutical intermediates and APIs. Under this agreement Degussa will ...

Rockwood Specialties Completes Acquisition of Four Dynamit Nobel Businesses To Form New Global Specialty Chemical Group

09-Aug-2004 - Specialties Group, Inc., Princeton (NJ), announced today that it has completed the acquisition of four businesses of Dynamit Nobel, Troisdorf (Germany), to form a new specialty chemicals and advanced materials group with pro forma combined revenue of approximately $2.5 billion in 2003. To create ...

Efficient large scale production of Pharmaceutical intermediates

14-Apr-2004 - Leading contract research company, Peakdale Molecular Ltd recently invested in two large-scale glass reaction systems from Radleys to help upgrade the capabilities of their Kilo Laboratory. The new facility is being used to produce a greater range of pharmaceutical intermediates more quickly ...